MOLTENI, LAURA
 Distribuzione geografica
Continente #
AS - Asia 4.383
NA - Nord America 4.132
EU - Europa 2.490
SA - Sud America 370
AF - Africa 47
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.427
Nazione #
US - Stati Uniti d'America 4.039
VN - Vietnam 2.241
SG - Singapore 863
IT - Italia 790
CN - Cina 578
DE - Germania 432
HK - Hong Kong 321
RU - Federazione Russa 310
BR - Brasile 299
IE - Irlanda 168
SE - Svezia 154
GB - Regno Unito 130
AT - Austria 90
IN - India 79
ID - Indonesia 76
FI - Finlandia 70
KR - Corea 64
CA - Canada 59
FR - Francia 59
UA - Ucraina 57
ES - Italia 45
PL - Polonia 44
BE - Belgio 33
DK - Danimarca 31
AR - Argentina 28
JP - Giappone 27
MX - Messico 27
TR - Turchia 26
TW - Taiwan 25
BD - Bangladesh 20
ZA - Sudafrica 20
CH - Svizzera 19
NL - Olanda 18
EC - Ecuador 13
CZ - Repubblica Ceca 9
IQ - Iraq 9
LT - Lituania 9
PY - Paraguay 9
IR - Iran 8
KE - Kenya 7
CO - Colombia 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
CL - Cile 5
EG - Egitto 5
MY - Malesia 5
PK - Pakistan 5
DZ - Algeria 4
IL - Israele 4
UZ - Uzbekistan 4
EE - Estonia 3
JM - Giamaica 3
MA - Marocco 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PH - Filippine 3
SN - Senegal 3
TN - Tunisia 3
UY - Uruguay 3
VE - Venezuela 3
AZ - Azerbaigian 2
BO - Bolivia 2
HU - Ungheria 2
JO - Giordania 2
LB - Libano 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
SA - Arabia Saudita 2
AL - Albania 1
AU - Australia 1
BH - Bahrain 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LI - Liechtenstein 1
NG - Nigeria 1
OM - Oman 1
RS - Serbia 1
SC - Seychelles 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 11.427
Città #
Ann Arbor 1.022
Ho Chi Minh City 703
Hanoi 582
Singapore 526
Ashburn 358
Hong Kong 319
Frankfurt am Main 316
Chandler 254
Milan 253
Wilmington 210
Dallas 197
Dublin 162
Woodbridge 161
Fairfield 144
Beijing 135
New York 114
Los Angeles 95
Dearborn 83
Vienna 81
Houston 79
Seattle 72
Hefei 71
Santa Clara 70
Haiphong 68
Jakarta 67
Biên Hòa 60
Da Nang 59
Princeton 58
Cambridge 53
Ha Long 48
Quận Bình Thạnh 46
Jacksonville 43
São Paulo 39
Buffalo 38
Helsinki 38
Rome 36
Shanghai 36
London 34
Munich 34
Nanjing 33
Seoul 33
Can Tho 32
Thái Nguyên 32
Hải Dương 31
Quận Một 31
Kent 30
Chicago 27
Brussels 26
Council Bluffs 26
Granada 26
Moscow 26
Ninh Bình 26
Quận Phú Nhuận 26
The Dalles 26
Bắc Ninh 25
Pune 25
Warsaw 23
Bắc Giang 22
Guangzhou 22
Tokyo 22
Nuremberg 21
Vũng Tàu 21
Fremont 20
Orem 19
Phủ Lý 19
Toronto 19
Lawrence 17
Denver 16
Turku 16
Vinh 16
Kaohsiung 15
Altamura 14
Monza 14
Poplar 14
Rio de Janeiro 14
Boardman 13
Boston 13
Nam Định 13
Quận Bảy 13
Quận Sáu 13
Romola 13
San Diego 13
Thu Dau Mot 13
Andover 12
Phoenix 12
Stockholm 12
Brooklyn 11
Lấp Vò 11
Quảng Ninh 11
Quận Bốn 11
Quận Năm 11
Điện Bàn 11
Ankara 10
Carate Brianza 10
Manchester 10
Tampa 10
Thanh Hóa 10
Thành Phố Bà Rịa 10
Huế 9
Hòa Bình 9
Totale 7.873
Nome #
Histone Deacetylase 6 Inhibitors: Mitigators Of Chemotherapy Induced Peripheral Neuropathy Via The NMNAT2/SARM1 Pathway Modulation 1.034
Evaluation of Histone Deacetylase 6 inhibitors as possible neuroprotectors against Paclitaxel-induced peripheral neurotoxicity 697
Study of the tissue distribution of TLQP-21 in mice using [18F]JMV5763, a radiolabeled Analog prepared via [18F]aluminum fluoride chelation chemistry 478
Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study 452
Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease 437
Anti-inflammatory effects of palmitoylethanolamide in activated microglial cells 424
Palmitoylethanolamide modulation of microglia activation: Characterization of mechanisms of action and implication for its neuroprotective effects 417
Growth hormone secretagogues and the regulation of calcium signaling in muscle 404
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 400
TLQP-21, A VGF-derived peptide endowed of endocrine and extraendocrine properties: Focus on in vitro calcium signaling 352
JMV5656, a short synthetic derivative of TLQP-21, alleviates acid-induced lung injury and fibrosis in mice 313
PHARMACOLOGICAL CHARACTERIZATION OF THE INTRACELLULAR SIGNALLING PATHWAY ACTIVATED BY TLQP-21 310
Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity 303
STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages 302
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 275
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis 272
Development of Growth Hormone Secretagogues as new therapeutical tools for Amyotrophic Lateral Sclerosis 267
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 251
Parma consensus statement on metabolic disruptors 251
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 250
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein 246
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 245
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury 238
TLQP-21 modulate inflammation and fibrosis in a model of ards 236
The Role of NMNAT2/SARM1 in Neuropathy Development 225
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 225
Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears 221
Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases 216
Functional and Structural Characterization of a Binding Site for TLQP-21, a VGF-Derived Peptide 194
Inibition of H2O2-induced neurotoxicity in mouse neuroblastoma Neuro2A cells by microvescicles released from hexarelin-stimulated microglial cells 173
PHARMACOLOGICAL CHARACTERIZATION OF A BINDING SITE FOR TLQP-21, A VGF-DERIVED PEPTIDE 169
Neural stem cells release soluble factors that modulate inflammatory cytokines expression in microglia 169
Antioxidant and neuroprotective effects of Hexarelin in Neuro-2A cells 158
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis: the case of hexarelin and JMV2894 140
Effects of hexarelin on the modulation of apoptosis pathway induced by hydrogen peroxide 138
Potential application of Growth Hormone Secretagogues (GHS) for Amyotrophic Lateral Sclerosis (ALS) treatment: mechanisms of action and neuroprotective effects characterization in human SH-SY5Y SOD1G93A cells 135
Evaluation of the neuroprotective effects of growth hormone secretagogues and glycosaminoglycans in an in vitro model of glutamate toxicity 112
Correction to: Parma consensus statement on metabolic disruptors (Environmental Health: A Global Access Science Source (2015) 14:1 (54) DOI: 10.1186/s12940-015-0042-7) 106
Transgenic zebrafish embryos to evaluate the in vivo effects of different liposome-paclitaxel nanocarrier system 104
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 103
Hexarelin reduces H2O2-induced oxidative stress in Neuro2A cell line 99
Neuroprotectiveeffectsof hexarelinin an in vitro model of ALS 99
Role of nutrition in degenerative disease 80
SARM1 modulation by HDAC6 inhibition as a neuroprotective strategy in chemotherapy-induced peripheral neuropathy 64
REDUCING PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY VIA LIPOSOMAL DRUG TARGETING 10
Targeted Paclitaxel Delivery Via Metalloproteinase-Sensitive Liposomes To Prevent Peripheral Neurotoxicity: A Proof Of Concept 8
Totale 11.802
Categoria #
all - tutte 32.321
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.321


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021556 0 0 0 0 0 0 83 90 87 85 99 112
2021/2022656 91 71 56 52 37 44 22 21 24 58 58 122
2022/20231.122 130 252 140 116 56 172 21 79 75 17 33 31
2023/2024726 26 39 41 53 76 202 121 28 42 13 14 71
2024/20251.993 96 132 118 120 156 120 165 62 131 250 177 466
2025/20264.828 2.138 836 485 574 517 268 10 0 0 0 0 0
Totale 11.802